Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04799275
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2021-03-13
Brief Title:
Testing CC-486 Oral Azacitidine Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ann Arbor Stage III Diffuse Large B-Cell Lymphoma |
| Ann Arbor Stage IIX Bulky Diffuse Large B-Cell Lymphoma |
| Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
| Diffuse Large B-Cell Lymphoma Activated B-Cell Type |
| Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation |
| Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type |
| Diffuse Large B-Cell Lymphoma Not Otherwise Specified |
| EBV-Positive Diffuse Large B-Cell Lymphoma Not Otherwise Specified |
| Grade 3b Follicular Lymphoma |
| HHV8-Positive Diffuse Large B-Cell Lymphoma Not Otherwise Specified |
| High Grade B-Cell Lymphoma With MYC and BCL2 andor BCL6 Rearrangements |
| High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements |
| High Grade B-Cell Lymphoma With MYC BCL2 and BCL6 Rearrangements |
| High Grade B-Cell Lymphoma Not Otherwise Specified |
| Intravascular Large B-Cell Lymphoma |
| Lymphoplasmacytic Lymphoma |
| Nodular Lymphocyte Predominant B-Cell Lymphoma |
| Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type |
| T-CellHistiocyte-Rich Large B-Cell Lymphoma |
| Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma |
| Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma |
Keywords: